Hologic Q4 Adj $0.89 Beats $0.84 Estimate, Sales $945.30M Beat $940.04M Estimate
Portfolio Pulse from Benzinga Newsdesk
Hologic (NASDAQ:HOLX) reported Q4 earnings of $0.89 per share, beating the analyst consensus estimate of $0.84 by 5.95%. This is an 8.54% increase over earnings of $0.82 per share from the same period last year. The company also reported quarterly sales of $945.30 million, beating the analyst consensus estimate of $940.04 million by 0.56%. However, this is a 0.81% decrease over sales of $953.00 million the same period last year.
November 09, 2023 | 9:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hologic's Q4 earnings and sales beat estimates, but sales saw a slight decrease compared to the same period last year.
Hologic's earnings beat estimates, which is generally a positive signal for the stock. However, the slight decrease in sales compared to the same period last year might temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100